Preliminary results of a Phase 1 dose escalation study of the first-in-class anti-CD74 antibody drug conjugate (ADC), STRO-001, in patients with advanced B-cell malignancies.

Please Click the Link, International Conference in Malignant Lymphoma 2019 poster to enlarge.